Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of aSPIrin Versus Aspirin Plus Low-dose RIvaroxaban on Carotid aTherosclerotic Plaque Inflammation

NCT05797376 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT05797376
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05797376 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of aSPIrin Versus Aspirin Plus Low-dose RIvaroxaban on Carotid aTherosclerotic Plaque Inflammation
Lead sponsor
Asan Medical Center
Phase
Phase 4
Overall status
Completed
Start date
August 24, 2021
Completion date
December 5, 2024
Enrollment
92 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis of artery, carotid stenosis, coronary artery disease, peripheral arterial disease